Blood Bank Management System 1.0 login.php Error cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.8 | $0-$5k | 0.00 |
Summary
A vulnerability has been found in Blood Bank Management System 1.0 and classified as problematic. This vulnerability affects unknown code of the file login.php. The manipulation of the argument Error leads to cross site scripting. This vulnerability is referenced as CVE-2025-63534. Remote exploitation of the attack is possible. No exploit is available.
Details
A vulnerability, which was classified as problematic, has been found in Blood Bank Management System 1.0. This issue affects an unknown part of the file login.php. The manipulation of the argument error with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. The summary by CVE is:
A cross-site scripting (XSS) vulnerability exists in the Blood Bank Management System 1.0 within the login.php component. The application fails to properly sanitize or encode user-supplied input before rendering it in response. An attacker can inject malicious JavaScript payloads into the msg and error parameters, which are then executed in the victim's browser when the page is viewed.
It is possible to read the advisory at github.com. The identification of this vulnerability is CVE-2025-63534 since 10/27/2025. The exploitation is known to be easy. The attack may be initiated remotely. It demands that the victim is doing some kind of user interaction. Technical details of the vulnerability are known, but there is no available exploit. The attack technique deployed by this issue is T1059.007 according to MITRE ATT&CK.
By approaching the search of inurl:login.php it is possible to find vulnerable targets with Google Hacking.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Type
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.8VulDB Meta Temp Score: 5.8
VulDB Base Score: 3.5
VulDB Temp Score: 3.4
VulDB Vector: 🔒
VulDB Reliability: 🔍
NVD Base Score: 5.4
NVD Vector: 🔒
CNA Base Score: 8.5
CNA Vector (MITRE): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Google Hack: 🔒
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
10/27/2025 CVE reserved12/01/2025 Advisory disclosed
12/01/2025 VulDB entry created
12/04/2025 VulDB entry last update
Sources
Advisory: github.comStatus: Not defined
CVE: CVE-2025-63534 (🔒)
GCVE (CVE): GCVE-0-2025-63534
GCVE (VulDB): GCVE-100-333875
Entry
Created: 12/01/2025 17:20Updated: 12/04/2025 07:50
Changes: 12/01/2025 17:20 (54), 12/01/2025 22:13 (11), 12/04/2025 07:50 (11)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.